CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

Erlotinib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 28 USDMF, 1 JDMF, 15 EU WC, 15 KDMF, 15 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

87 FDF Dossiers, 41 FDA Orange Book, 21 Europe, 10 Canada, 11 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 17 Granulation, 15 Controlled & Modified Release, 14 Direct Compression, 14 Disintegrants & Superdisintegrants, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 8 Co-Processed Excipients, 6 Film Formers & Plasticizers, 6 Taste Masking, 5 Empty Capsules, 4 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Coloring Agents, 3 API Stability Enhancers, 2 Emulsifying Agents, 1 Topical, 1 Parenteral, 1 Surfactant & Foaming Agents, 1 Solubilizers

DIGITAL CONTENT

12 News #PharmaBuzz

12 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 3 Regulatory FDF Prices

MARKET PLACE

3 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
03/10/2025	Alembic Pharmaceuticals Limited	India	M/s Alembic Pharmaceuticals limited	WC-0082	Erlotinib Hydrochloride IH	2025-08-22	2028-08-21	Karakhadi, Plot No. 842-843, At - Karakhdi, Tal. - Padra, Dist -Vadodara, Gujarat, India
04/06/2025	BDR Lifesciences	India	M/s BDR lifesciences Pvt Ltd	WC-0340	Erlotinib Hydrochloride IH	2022-09-30	2025-04-14	R.S No: 578, Near Effluent Channel, at & Post: Luna, Taluka: Padra, District: Vadodara-391440, India

Erlotinib Hydrochloride

Erlotinib Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

67 API Suppliers

28 USDMF

1 JDMF

15 EU WC

15 KDMF

15 NDC API

29 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

87 FDF Dossiers

41 FDA Orange Book

21 Europe

10 Canada

11 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

4 DKSH

4 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 ACG Worldwide

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

10 Corel Pharma Chem

5 DFE Pharma

5 Gangwal Chemicals

4 Ideal Cures

1 Ingredion Pharma Solutions

19 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

10 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

2 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

11 Roquette

6 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives

30 Fillers, Diluents & Binders

17 Granulation

15 Controlled & Modified Release

14 Direct Compression

14 Disintegrants & Superdisintegrants

12 Thickeners and Stabilizers

12 Lubricants & Glidants

8 Co-Processed Excipients

6 Film Formers & Plasticizers

6 Taste Masking

5 Empty Capsules

4 Rheology Modifiers

4 Chewable & Orodispersible Aids

4 Vegetarian Capsules

4 Coloring Agents

3 API Stability Enhancers

TABLET;ORAL - EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 25MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons